(Q40087975)

17 September 2017

title

Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer (English)

1 reference

17 September 2017

1 reference

2

Hideki Enokida

1 reference

17 September 2017

Takashi Arima

1

1 reference

17 September 2017

Hiroyuki Kubo

3

1 reference

17 September 2017

Ichiro Kagara

4

1 reference

17 September 2017

Ryouichirou Matsuda

5

1 reference

17 September 2017

Kazuki Toki

6

1 reference

17 September 2017

Hiroaki Nishimura

7

1 reference

17 September 2017

Takeshi Chiyomaru

8

1 reference

17 September 2017

Shuichi Tatarano

9

1 reference

17 September 2017

Toshihiko Idesako

10

1 reference

17 September 2017

Kenryu Nishiyama

11

1 reference

17 September 2017

Masayuki Nakagawa

12

1 reference

17 September 2017

language of work or name

1 reference

28 August 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

98

1 reference

17 September 2017

issue

11

1 reference

17 September 2017

page(s)

1720-1726

1 reference

Shedding light on ADAM metalloproteinases

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

The ADAMs family of metalloproteases: multidomain proteins with multiple functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Protein ectodomain shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Regulation of APP cleavage by alpha-, beta- and gamma-secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

ADAM-17 expression in breast cancer correlates with variables of tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Targeting ADAMS and ERBBs in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

ADAMs in cancer cell proliferation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

ADAMs, cell migration and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Interaction of IGF signaling and the androgen receptor in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Oxidative stress induces ADAM9 protein expression in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Nuclear import of the human androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

Increased expression of ADAM family members in human breast cancer and breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

ADAM-10 protein is present in human articular cartilage primarily in the membrane-bound form and is upregulated in osteoarthritis and in response to IL-1alpha in bovine nasal cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00601.X

10.1111/J.1349-7006.2007.00601.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference